Home › Funds › Artia Global Partners LP › RVMD

Artia Global Partners LP position in RVMD

REVOLUTION MEDICINES INC · Health Care

Artia Global Partners LP reported holding 185,390 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$34.7M, representing 6.41% of its reported portfolio and ranking #5 among its reported holdings. Artia Global Partners LP has disclosed RVMD holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)185.39K sh
Reported value held$34.72M
Portfolio Weight6.41%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's RVMD position evolved

Artia Global Partners LP first disclosed a stake in RVMD in Q3 2024 at 95,885 shares (US$4.3M). The position peaked in Q2 2026 at 185,390 shares, worth US$34.7M. Across 8 filings, Artia Global Partners LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 185,390 shares valued at US$34.7M — an increase of 60,400 shares quarter over quarter.. Notable position changes include a 196% increase in Q4 2024 (shares fell 19% over the following quarter), a 63% trim in Q1 2025 (shares rose 4% over the following quarter), a 48% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 95.89K $4.35M New
Q4 2024 284.19K $12.43M Add
Q1 2025 104.19K $3.68M Reduce
Q2 2025 104.19K $3.83M Hold
Q3 2025 104.19K $4.87M Hold
Q4 2025 104.19K $8.30M Hold
Q1 2026 124.99K $12.16M Add
Q2 2026 185.39K $34.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 61 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Artia Global Partners LP held RVMD?

Artia Global Partners LP has disclosed RVMD holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Artia Global Partners LP's current position in RVMD?

As of Q2 2026, Artia Global Partners LP holds 185.39K shares of RVMD (REVOLUTION MEDICINES INC), valued at $34.72M, representing 6.41% of its reported portfolio and ranking #5.

Has Artia Global Partners LP been buying or selling RVMD?

In the latest 13F filing (Q2 2026), Artia Global Partners LP increased its position in RVMD. The position peaked in Q2 2026 at 185.39K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.